Unlabelled: Background/Study Context: A number of longitudinal randomized controlled trials (LRCT) have used free verbal recall tests to study the effects of post-menopausal estrogen hormone therapy (HT) on episodic memory, but none have explicitly explored contrasts between list and story recall, in spite of cognitive differences between the tasks. For example, list recall provides little support for the use of gist, while story recall emphasizes it, and there is evidence that estrogen produces gist bias. Moreover, we present a literature tabulation that also suggests a task-specific HT effect.
Methods: In an LRCT with up to eight yearly test sessions, post-menopausal women were randomly assigned either to placebo (N = 56) or to an estrogen formulation (N = 44); subgroups received either estrogen alone (hysterectomy; E-alone; N = 16) or with progestin (intact uterus; E + P; N = 28). Participants were tested on the immediate and delayed list and story recall at each session.
Results: Linear mixed effects analyses of longitudinal trajectories showed that relative to placebo, the HT group declined significantly faster on immediate list recall and slower on immediate story recall. Separate analyses produced a sharpened version of this pattern for the E-alone subgroup but found no significant effects for the E + P subgroup. No significant effects were found in delayed testing.
Conclusion: The dissociation we found for immediate list and story recall is similar to the pattern of results in our literature tabulation. Fuzzy-Trace Theory posits parallel verbatim and gist traces plus a meta-cognitive review which becomes more gist-biased with age. Our results suggest that: (1) estrogen increases gist bias, hastening the normal age-related decline of list recall but slowing the decline of story recall relative to placebo; (2) decay of the verbatim trace over time generally causes a shift to gist, thereby accounting for the absence of a delayed recall difference; and (3) progestin weakens the effects of estrogen, thereby accounting for why the dissociation found in E-alone was absent in the E + P subgroup.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535049 | PMC |
http://dx.doi.org/10.1080/0361073X.2019.1609169 | DOI Listing |
Alzheimers Dement
December 2024
Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Background: South Asian (SA) older adults are one of the fastest growing US populations developing Alzheimer's disease (AD) and related dementias (ADRD). Compared to non-Hispanic white (NHW) Americans, SA are hesitant to enroll in neuropsychological and MRI research. This status complicates accurate assessment and diagnosis.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Linguistic Data Consortium, University of Pennsylvania, Philadelphia, PA, USA.
Background: Story recall tasks are often employed in clinical settings to measure verbal episodic memory in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Traditional analyses (e.g.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Harvard T.H. Chan School of Public Health, Cambridge, MA, USA.
Background: Informant reports are commonly regarded as reliable and supplemental alongside respondent cognitive assessments, particularly in low-literacy settings with absent normative data. We evaluate the performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) in rural South Africa.
Method: This study utilizes data from the Cognition and Dementia in a Longitudinal Health and Aging Study in South Africa (HAALSI-HCAP).
Alzheimers Dement
December 2024
Wisconsin Alzheimer's Institute, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Background: Previous studies have found connections between recall of proper names (PN) and amyloid positivity in cognitively unimpaired (CU) adults at risk for Alzheimer's Disease (AD; Mueller et al., 2020). Given the promising prospect of employing plasma-based biomarkers to determine amyloid burden, we looked at associations between longitudinal change in PN and total score recall from Logical Memory (LM) story recall test and plasma pTau217.
View Article and Find Full Text PDFBackground: Subjective cognitive decline (SCD), or a person's perception of changes in their cognitive abilities, has been identified as a possible early marker of preclinical Alzheimer's disease (AD) in non-Hispanic Whites; however, research is lacking about the clinical utility of SCD in diverse populations. This study investigated the associations of self and informant reports of SCD, plasma biomarker profiles of AD, and objective cognitive performance in Hispanic older adults living in Miami.
Method: Hispanic participants enrolled in the 1Florida Alzheimer's Disease Research Center who completed neuropsychological testing and blood draws for biomarker analysis were eligible.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!